|
|
||||||||
1Research, 2Medical and 3Pathology Services, Veterans Affairs Medical Center, Memphis 38104; and Departments of 4Medicine, 5Pathology, and 6Pharmacology, and 7College of Medicine, University of Tennessee, the Health Science Center, Memphis, Tennessee 38163
Submitted 31 March 2003 ; accepted in final form 21 May 2003
Both insulin and glucagon stimulate steady-state levels of Sp1 transcription factor, but only insulin stimulates transcription of the calmodulin (CaM) gene in liver. Because O-glycosylation of Sp1 by O-linked N-acetylglucosamine (O-GlcNAc) is thought to regulate its ability to activate transcription, we assayed the levels of Sp1 with anti-Sp1 and anti-O-GlcNAc antibodies in Western blots by use of extracts of H-411E liver cells treated with insulin (10,000 µU/ml) or glucagon (1.5 x 10-5 M). We also assessed subcellular localization of the native and glycosylated Sp1 in H411E cells treated with either hormone in the presence of deoxynorleucine (DON, an indirect inhibitor of O-glycosylation) or streptozotocin (STZ, an indirect stimulator of O-glycosylation). Insulin stimulated both total and O-GlcNAc-modified Sp1 primarily in the nucleus and induced CaM gene transcription (P < 0.0001). In contrast, glucagon promoted accumulation of Sp1 in the cytoplasm but not the nucleus, without significantly stimulating (P = not significant) either its O-glycosylation or transcription of the CaM gene. DON inhibited O-glycosylation of Sp1 and its ability to migrate to the nucleus and transactivate CaM gene transcription. In contrast, cotreatment of cells with STZ and glucagon enhanced O-glycosylation of Sp1, promoting its migration to the nucleus and resulting in increased CaM gene transcription. Thus O-glycosylation of Sp1 by insulin, but not glucagon, apparently enhances its (Sp1) nuclear recruitment and results in activation of CaM gene transcription.
Sp1 transcription factor; calmodulin gene transcription; liver cells; diabetes mellitus
This article has been cited by other articles:
![]() |
N. Noach, Y. Segev, I. Levi, S. Segal, and E. Priel Modification of Topoisomerase I Activity by Glucose and by O-Glcnacylation of the Enzyme Protein Glycobiology, December 1, 2007; 17(12): 1357 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Sacksteder, J. E. Whittier, Y. Xiong, J. Li, N. A. Galeva, M. E. Jacoby, S. O. Purvine, T. D. Williams, M. C. Rechsteiner, D. J. Bigelow, et al. Tertiary Structural Rearrangements upon Oxidation of Methionine145 in Calmodulin Promotes Targeted Proteasomal Degradation Biophys. J., August 15, 2006; 91(4): 1480 - 1493. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Vij and P. L. Zeitlin Regulation of the ClC-2 Lung Epithelial Chloride Channel by Glycosylation of SP1 Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 754 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ye, D. Shedd, and G. Miller An Sp1 Response Element in the Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame 50 Promoter Mediates Lytic Cycle Induction by Butyrate J. Virol., February 1, 2005; 79(3): 1397 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Majumdar, J. Wright, P. Markowitz, A. Martinez-Hernandez, R. Raghow, and S. S. Solomon Insulin Stimulates and Diabetes Inhibits O-Linked N-Acetylglucosamine Transferase and O-Glycosylation of Sp1 Diabetes, December 1, 2004; 53(12): 3184 - 3192. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |